BioXcel Therapeutics' GAAP loss for 2021 was $106.931 million, up 30.1% from $82.169 million the previous year.
BioXcel Therapeutics' GAAP loss for 2021 was $106.931 million, up 30.1% from $82.169 million the previous year.
BioXcel Therapeutics reports for 2021
BioXcel Therapeutics' GAAP loss for 2021 was $106.931 million, up 30.1% from $82.169 million the previous year. Source: 
ir.bioxceltherapeutics.com
ir.bioxceltherapeutics.com
English (US) 